President and CEO of Exelixis Inc (30-Year Financial, Insider Trades) Michael Morrissey (insider trades) sold 34,721 shares of EXEL on 07/17/2019 at an average price of $21.37 a share. The total sale was $741,988.
Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company. Exelixis Inc has a market cap of $6.42 billion; its shares were traded at around $21.27 with a P/E ratio of 10.23 and P/S ratio of 7.79. GuruFocus has detected 1 severe warning sign with Exelixis Inc. .
CEO Recent Trades:
- President and CEO Michael Morrissey sold 34,721 shares of EXEL stock on 07/17/2019 at the average price of $21.37. The price of the stock has decreased by 0.47% since.
- President and CEO Michael Morrissey sold 34,721 shares of EXEL stock on 07/03/2019 at the average price of $21.03. The price of the stock has increased by 1.14% since.
Directors and Officers Recent Trades:
- Sr. Vice President, Commercial Patrick J. Haley sold 1,000 shares of EXEL stock on 07/10/2019 at the average price of $20.96. The price of the stock has increased by 1.48% since.
- Director George A Scangos sold 40,000 shares of EXEL stock on 07/01/2019 at the average price of $21.58. The price of the stock has decreased by 1.44% since.
For the complete insider trading history of EXEL, click here
.
